New York Mesothelioma

Staging and Clinical Trials for Asbestos-Related Cancer

Mesothelioma attorneys in New York present important facts

When searching for a mesothelioma attorney, New York residents turn to Seeger Weiss LLP, a law firm that brings a heralded track record to litigating mesothelioma cases. Mesothelioma is an aggressive form of cancer that is caused by exposure to asbestos, primarily in the workplace but also at home and in other locales.

In New York, mesothelioma research continues to uncover more information about this disease that strikes between 2,000 and 3,000 people per year in the United States alone. Seeger Weiss LLP, a law firm composed of knowledgeable mesothelioma attorneys in New York, wants to help you understand the disease and how it is being studied.

Overview of mesothelioma

Unlike cancers that typically manifest in lumpy growths, mesothelioma most often grows from the lung lining and exerts pressure on nearby organs. The disease can also affect the heart and abdominal organs. In lung cases, mesothelioma creates a casing around the lung, making it increasingly difficult for the patient to breathe deeply.

The only known cause of mesothelioma is exposure to asbestos. An experienced mesothelioma attorney in New York stays abreast of the latest medical research and can litigate for individuals who have contracted this disease. Many people have been able to recover damages with the help of a skilled mesothelioma attorney. New York residents in their times of need trust Seeger Weiss LLP as a source of expert legal knowledge and support.

Clinical trials

In New York, mesothelioma clinical trials employ strict protocols to dictate what will be studied and how the results will be evaluated. Approval is normally secured by review boards before patients become involved. Trials may include the following components:

Phase I studies the safety of potential mesothelioma drugs. Doctors discover the best method to administer the drug, how the drug is eliminated from the body and any side effects. During Phase I, drugs are given to small, select groups of patients.

Larger groups receive the drug during Phase II. Here, doctors closely study the effects of the drug by carefully monitoring how the disease responds. Side effects are also noted and recorded.

In Phase III, clinicians compare results of the new drug to those of existing treatments. Patients may be divided into two groups, neither of which may know what drug they’re receiving.

After a drug has gained FDA approval, Phase IV begins, and the drug itself is closely examined. These studies are often sponsored by drug companies.

In New York, mesothelioma clinical trials have taken place in established research centers such as Columbia-Presbyterian Medical Center, Columbia University Medical Center and the Biomedical Research Alliance of New York.

New York mesothelioma attorneys are standing by

If you have been diagnosed with mesothelioma or have any of its symptoms, contact Seeger Weiss LLP, the mesothelioma attorneys in New York who care about you and want you to receive the judgment you deserve.